|
Volumn 1470, Issue 3, 2000, Pages
|
Molecular horizons of cancer therapeutics: 11th Pezcoller Symposium
|
Author keywords
Angiogenesis; Apoptosis; Cell cycle; Hypoxia; Oncogene; Tumor
|
Indexed keywords
PROTEIN P53;
ANGIOGENESIS;
APOPTOSIS;
CANCER;
CELL CYCLE PHASE;
CONFERENCE PAPER;
DNA SEQUENCE;
HUMAN;
HYPOXIA;
ONCOGENE;
PRIORITY JOURNAL;
TRANSCRIPTION REGULATION;
ACETYLTRANSFERASES;
ADENOVIRIDAE;
ADENOVIRUS E1B PROTEINS;
ANIMALS;
ANTIBODIES;
APOPTOSIS;
CARRIER PROTEINS;
CDC2-CDC28 KINASES;
CELL CYCLE PROTEINS;
CLINICAL TRIALS;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLIN-DEPENDENT KINASES;
CYCLINS;
DNA-BINDING PROTEINS;
DRUG DESIGN;
E2F TRANSCRIPTION FACTORS;
ENDOTHELIAL GROWTH FACTORS;
HISTONE ACETYLTRANSFERASES;
HUMANS;
LYMPHOKINES;
MICE;
NEOPLASMS;
ONCOGENE PROTEINS;
PROTEIN-SERINE-THREONINE KINASES;
PROTEINS;
RATS;
SIGNAL TRANSDUCTION;
TRANSCRIPTION FACTOR DP1;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P14ARF;
TUMOR SUPPRESSOR PROTEIN P53;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0034679092
PISSN: 0304419X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0304-419X(00)00008-1 Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|